| Product Code: ETC9964616 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Drug Testing Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Drug Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Drug Testing Market - Industry Life Cycle |
3.4 United States (US) Drug Testing Market - Porter's Five Forces |
3.5 United States (US) Drug Testing Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 United States (US) Drug Testing Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.7 United States (US) Drug Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 United States (US) Drug Testing Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 United States (US) Drug Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and regulations regarding workplace drug testing |
4.2.2 Rising incidence of drug abuse and addiction in the United States |
4.2.3 Growing adoption of drug testing in healthcare settings |
4.3 Market Restraints |
4.3.1 High costs associated with drug testing procedures |
4.3.2 Legal and ethical concerns related to privacy and discrimination |
4.3.3 Lack of standardization in drug testing practices across different industries |
5 United States (US) Drug Testing Market Trends |
6 United States (US) Drug Testing Market, By Types |
6.1 United States (US) Drug Testing Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Drug Testing Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 United States (US) Drug Testing Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 United States (US) Drug Testing Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.5 United States (US) Drug Testing Market Revenues & Volume, By Rapid Testing Devices, 2021- 2031F |
6.1.6 United States (US) Drug Testing Market Revenues & Volume, By Services, 2021- 2031F |
6.2 United States (US) Drug Testing Market, By Sample Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Drug Testing Market Revenues & Volume, By Urine samples, 2021- 2031F |
6.2.3 United States (US) Drug Testing Market Revenues & Volume, By Oral Fluid Samples, 2021- 2031F |
6.2.4 United States (US) Drug Testing Market Revenues & Volume, By Hair Sample, 2021- 2031F |
6.2.5 United States (US) Drug Testing Market Revenues & Volume, By Other Samples, 2021- 2031F |
6.3 United States (US) Drug Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Drug Testing Market Revenues & Volume, By Alcohol, 2021- 2031F |
6.3.3 United States (US) Drug Testing Market Revenues & Volume, By Cannabis/Marijuana, 2021- 2031F |
6.3.4 United States (US) Drug Testing Market Revenues & Volume, By Cocaine, 2021- 2031F |
6.3.5 United States (US) Drug Testing Market Revenues & Volume, By Opioids, 2021- 2031F |
6.3.6 United States (US) Drug Testing Market Revenues & Volume, By Amphetamine & Methamphetamine, 2021- 2031F |
6.3.7 United States (US) Drug Testing Market Revenues & Volume, By LSD, 2021- 2031F |
6.4 United States (US) Drug Testing Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Drug Testing Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Drug Testing Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 United States (US) Drug Testing Market Revenues & Volume, By Other End Uses, 2021- 2031F |
7 United States (US) Drug Testing Market Import-Export Trade Statistics |
7.1 United States (US) Drug Testing Market Export to Major Countries |
7.2 United States (US) Drug Testing Market Imports from Major Countries |
8 United States (US) Drug Testing Market Key Performance Indicators |
8.1 Percentage increase in the number of workplace drug testing programs implemented annually |
8.2 Average turnaround time for drug test results |
8.3 Number of drug testing labs accredited by regulatory bodies |
8.4 Adoption rate of advanced drug testing technologies |
8.5 Percentage of positive drug test results in the United States |
9 United States (US) Drug Testing Market - Opportunity Assessment |
9.1 United States (US) Drug Testing Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 United States (US) Drug Testing Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.3 United States (US) Drug Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 United States (US) Drug Testing Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 United States (US) Drug Testing Market - Competitive Landscape |
10.1 United States (US) Drug Testing Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Drug Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here